Biotech

All Articles

Former Seagen CEO unveils brand new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was marketed to Pfizer in 2014 for an immense...

Ironwood makes more bid for $1B GI medication with new subgroup information

.On the heels of a stage 3 succeed that fell short to wow entrepreneurs, Ironwood Pharmaceuticals is...

Novartis inks $150M offer for autoimmune molecular glue

.Do not cease Monte Rosa Rehabs currently. The Boston-based biotech is actually enjoying after autho...

Jade carves out director team with Chinook veterinarians-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant management hirings, firings a...

Septerna goes social along with upsized offering of $288M

.Celebrating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...

AbbVie brings in Richter richer, paying out $25M to create discovery treaty

.AbbVie has actually gone back to the resource of its antipsychotic powerhouse Vraylar trying to fin...

GenSight enters into ultimate full weeks of cash runway as earnings flow slips by of reach

.GenSight Biologics is actually weeks off of running out of funds. Once again. The biotech simply ha...

AZ licenses thrown away rare condition medication to Monopar Rehabs

.Monopar Therapeutics is actually recouping a drug from the dump of AstraZeneca's unusual disease pi...

Arcus' brand new HIF-2a information in renal cancer mention potential advantage over Merck's Welireg, experts mention

.With new information out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of experts ...

Roche bets around $1B to extend Dyno gene treatment shipping deal

.After creating a genetics treatment partnership with Dyno Therapeutics in 2020, Roche is back for a...